Digital Health and Telemedicine ETF
Overview
Notice: Fund to close on 17 January 2025
Betashares, the responsible entity of the Fund, has applied to the ASX for the trading status of the Fund to be revoked and for the Fund to be delisted. The ASX has approved this application. The last day units in the Fund will trade on the ASX will be 17 January 2025. For more information regarding key dates and options available to investors, please refer to the ASX announcement.
Fund objective
EDOC aims to track the performance of an index (before fees and expenses) that provides exposure to a portfolio of leading global digital healthcare companies.
Benefits
Access the growth potential of the digital health revolution
Healthcare spending is projected to rise as populations age and income levels increase. Spending is also likely to increasingly favour digital health solutions over the traditional way of delivering healthcare.
Exposure to leading digital healthcare companies
EDOC provides exposure to a portfolio of leading global digital healthcare companies from sectors such as telehealth, medical devices, wearables, remote patient monitoring, and digital healthcare software.
Convenient, cost-effective exposure
With management costs of only 0.67% p.a. (or $67 for every $10,000 invested), EDOC provides cost-effective exposure to the digital health and telemedicine thematic in a single ASX trade.*
Invest in EDOC with Betashares Direct
Key facts
Profile
| Units outstanding* (#) | 160,000 |
|---|---|
| Management fee and cost** (p.a.) | 0.67% |
| Distribution frequency | At least annually |
| Distribution reinvestment plan (DRP) | Full or partial participation available |
| Issuer | Betashares Capital Ltd |
| Registry | Link Market Services |
* As at 11 December 2024
**Certain additional costs apply. Please refer to PDS.
Pricing information
| Current price | |
|---|---|
| Last trade* | |
| % Change (prev day) | |
| Bid (delayed) | |
| Offer (delayed) | |
| NAV | * As at 11 December 2024 |
| NAV/Unit* | $10.34 |
| * Data is delayed by at least 20 minutes. | |
Past performance is not indicative of future performance. Please refer to "Fund returns after fees" for additional information regarding performance/return information.
Trading information
| ASX code | EDOC |
|---|---|
| Bloomberg code | EDOC AU |
| IRESS code | EDOC.AXW |
| Market makers | Susquehanna Pacific |
Index information
| Index | NASDAQ CTA Global Digital Health Index |
|---|---|
| Index provider | Nasdaq |
| Index ticker | N/A |
| Bloomberg index ticker | BEWELLAN Index |
Performance
Fund returns after fees (%)
| Fund | Index | |
|---|---|---|
| 1 month | 9.39% | 9.51% |
| 3 months | 18.46% | 18.75% |
| 6 months | 15.30% | 15.80% |
| 1 year | 14.01% | 14.89% |
| 3 year p.a. | - | -12.37% |
| 5 year p.a. | - | -0.30% |
| 10 year p.a. | - | - |
| Since inception (p.a.) | -6.53% | -5.83% |
| Inception date | 28-Mar-22 | - |
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.
Holdings and allocation
Portfolio holdings
| Name | Weight (%) |
|---|---|
| INSULET CORP | 9.7 |
| BOSTON SCIENTIFIC CORP | 8.0 |
| RESMED INC | 7.4 |
| DEXCOM INC | 7.3 |
| ABBOTT LABORATORIES | 7.1 |
| HIMS & HERS HEALTH INC | 6.7 |
| DOXIMITY INC | 5.1 |
| JD HEALTH INTERNATIONAL INC | 5.0 |
| MASIMO CORP | 4.9 |
| ALIBABA HEALTH INFORMATION TEC | 4.0 |
Sector allocation
| Health Care Equipment | 52.6% |
|---|---|
| Health Care Technology | 15.0% |
| Health Care Services | 15.0% |
| Drug Retail | 14.0% |
| Managed Health Care | 3.1% |
| Insurance Brokers | 0.3% |
* As of 29 November 2024
Country allocation
| United States | 81.1% |
|---|---|
| China | 9.8% |
| Japan | 4.5% |
| Netherlands | 3.5% |
| Switzerland | 0.6% |
| South Korea | 0.2% |
| Other | 0.3% |
* As of 29 November 2024
Recent distributions
| Ex Date | Record Date | Payment Date | Distribution Unit ($) | Annual Distribution Return (%) (1) |
|---|---|---|---|---|
| 1-Jul-24 | 2-Jul-24 | 16-Jul-24 | - | - |
| 2-Jan-24 | 3-Jan-24 | 17-Jan-24 | - | - |
| 3-Jul-23 | 4-Jul-23 | 18-Jul-23 | - | - |
| 3-Jan-23 | 4-Jan-23 | 18-Jan-23 | - | - |
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.